Dr. Tiffany Tahata, DO

NPI: 1942820337
Total Payments
$416.28
2024 Payments
$41.68
Companies
5
Transactions
12

Payment Breakdown by Category

Food & Beverage$416.28 (100.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $416.28 12 100.0%

Top Paying Companies

Company Total Records Latest Year
Novo Nordisk Inc $164.04 3 $0 (2023)
Indivior Inc. $93.70 4 $0 (2024)
BIOTRONIK INC. $73.74 1 $0 (2023)
Braeburn Inc. $55.11 3 $0 (2024)
ViiV Healthcare Company $29.69 1 $0 (2023)

Payment History by Year

Year Amount Transactions Top Company
2024 $41.68 2 Braeburn Inc. ($22.30)
2023 $249.60 9 Indivior Inc. ($74.32)
2022 $125.00 1 Novo Nordisk Inc ($125.00)

All Payment Transactions

12 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
04/05/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $22.30 General
Category: Opioid Use Disorder
02/13/2024 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $19.38 General
Category: OUD
11/07/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $23.69 General
Category: OUD
10/10/2023 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $14.81 General
Category: Opioid Use Disorder
10/04/2023 Braeburn Inc. BRIXADI (Drug) Food and Beverage In-kind items and services $18.00 General
Category: Opioid Use Disorder
09/26/2023 ViiV Healthcare Company APRETUDE (Biological) Food and Beverage In-kind items and services $29.69 General
Category: HIV
09/13/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $23.52 General
Category: OUD
07/12/2023 Indivior Inc. SUBLOCADE (Drug) Food and Beverage In-kind items and services $27.11 General
Category: OUD
02/16/2023 BIOTRONIK INC. Orsiro Mission (Device) Food and Beverage In-kind items and services $73.74 General
Category: Cardiology/Vascular Diseases
02/16/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $22.29 General
Category: Diabetes
01/05/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $16.75 General
Category: Diabetes
04/20/2022 Novo Nordisk Inc Ozempic (Drug) Food and Beverage In-kind items and services $125.00 General
Category: Diabetes

About Dr. Tiffany Tahata, DO

Dr. Tiffany Tahata, DO is a Addiction Medicine healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/25/2020. The National Provider Identifier (NPI) number assigned to this provider is 1942820337.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Tiffany Tahata, DO has received a total of $416.28 in payments from pharmaceutical and medical device companies, with $41.68 received in 2024. These payments were reported across 12 transactions from 5 companies. The most common payment nature is "Food and Beverage" ($416.28).

Practice Information

  • Specialty Addiction Medicine
  • Location Chicago, IL
  • Active Since 04/25/2020
  • Last Updated 06/25/2024
  • Taxonomy Code 207RA0401X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1942820337

Products in Payments

  • Ozempic (Drug) $125.00
  • SUBLOCADE (Drug) $93.70
  • Orsiro Mission (Device) $73.74
  • BRIXADI (Drug) $55.11
  • Rybelsus (Drug) $39.04
  • APRETUDE (Biological) $29.69

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Addiction Medicine Doctors in Chicago